No.

Publication Date

Citing Article

1

2025

Sandra Torres, Josiah Hardesty, Monica Barrios, Carmen Garcia-Ruiz, Jose C. Fernandez-Checa, Ashwani K. Singal. Mitochondria and Alcohol-Associated Liver Disease: Pathogenic Role and Target for Therapy, Seminars in Liver Disease. 2025; 45: 180.  https://doi.org/10.1055/a-2421-5658

2

2024

Laura Fàbrega, José C. Fernández-Checa, Laura Conde de la Rosa, Carmen Garcia-Ruiz. Impact of mitochondrial lipid alterations on liver disease mechanisms and progression, Exploration of Digestive Diseases. 2024; 382.  https://doi.org/10.37349/edd.2024.00057

3

2024

Hala Saeed Jaara, Sandra Torres. Mitochondrial ROS, a trigger for mitochondrial dysfunction and inflammasome activation and a therapeutic target in liver diseases, Exploration of Digestive Diseases. 2024; 3: 474.  https://doi.org/10.37349/edd.2024.00062

4

2025

Carlo Acierno, Fannia Barletta, Alfredo Caturano, Riccardo Nevola, Ferdinando Carlo Sasso, Luigi Elio Adinolfi, Luca Rinaldi. Alcohol Consumption and Liver Metabolism in the Era of MASLD: Integrating Nutritional and Pathophysiological Insights, Nutrients. 2025; 17: 2229.  https://doi.org/10.3390/nu17132229

5

2025

Mona M Watany, Marwa M Elhosary. Differential NADP-Dependent Isocitrate Dehydrogenases Expression in Metabolically Healthy Obesity vs Metabolic Syndrome: A Probable Predictive Biomarker for Metabolic Deterioration, The Journal of Applied Laboratory Medicine. 2025; jfaf124.  https://doi.org/10.1093/jalm/jfaf124

6

2025

Arman Farahani, Aryan Farahani, Khosrow Kashfi, Asghar Ghasemi. Inhibition of hepatic gluconeogenesis in type 2 diabetes by metformin: complementary role of nitric oxide, Medical Gas Research. 2025; 15: 507.  https://doi.org/10.4103/mgr.MEDGASRES-D-24-00100